Crossmark

Mepolizumab for severe eosinophilic asthma – A one-year real life Portuguese study

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2021.05.007

Published Online: 2025-03-10

Published Print: 2021-11-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Brás, R. https://orcid.org/0000-0002-3059-786X
Paulino, M. https://orcid.org/0000-0002-2568-3333
Varandas, C.

Coutinho, C. https://orcid.org/0000-0002-2072-8002
Silva, M.I. https://orcid.org/0000-0002-8041-1306
Limão, R.

Costa, C. https://orcid.org/0000-0001-8313-1505
Alonso, E.

Pedro, E.

Mendes, A.
License Information

Version of Record valid from 2021-11-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2021-03-24

Accepted: 2021-05-24

Published: 2025-03-10